跳至主要内容
临床试验/NCT03130361
NCT03130361已完成不适用

Evaluation of the Impact of a Wearable Noninvasive Positive Pressure Ventilation Device on Physical Activity and Quality of Life in Patients With COPD

Icadom14 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年1月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Icadom
入组人数
40
试验地点
14
主要终点
Change of daily physical activity measured by actimetry

研究概览

简要总结

The objective is to assess the impact of a wearable Noninvasive Positive Pressure Ventilation, on physical activity and quality of life in patients with severe COPD, complaining of dyspnea.

详细描述

In order to avoid the occurrence of uncomfortable dyspnea, patients with Chronic Obstructive Pulmonary Disease (COPD) are locked in a vicious circle of inactivity and social isolation which profoundly affects their quality of life and prognosis. A new wearable non invasive positive pressure ventilation device has been recently proposed; it can be used by intermittence during or after physical activities for reducing dyspnea or for shortening dyspnea- recovery time. The investigators hypothesize that this system, in reducing the inconvenience caused by dyspnea, would stimulate a more active lifestyle and improve quality of life. Their objective is to assess the impact of this device on physical activity and quality of life in patients with severe COPD, complaining of dyspnea.

In this open study with no control group, participants will use the device at their convenience, according to their needs in daily life and for 4 weeks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
35 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with stable severe COPD (with FEV1 ≤50% predicted)
  • Patients with mMRC score > ou = 2.

排除标准

  • Exacerbate within a month prior.
  • Using other non invasive ventilation device > 15h per day.
  • Have musculoskeletal or neuromuscular problem affecting balance and walking.
  • Have cognitive problem affecting comprehension of the different évaluations or questionnaires.
  • Have recently participated in physical training or rehabilitation program (≤ 3 months).
  • Medical contra-indication to NIV.
  • Evolutionary pathologies (excluding COPD) may be life-threatening in the short term (1 year) (cancer, neuromuscular disease rapidly changing).
  • Simultaneously enrolled in an other clinical trial.
  • Not affiliated to social security.
  • Person deprived of liberty, major protected by law.

研究组 & 干预措施

Noninvasive ventilation

Experimental

Participants will use the device at home by intermittence during or after physical activities for reducing dyspnea or for shortening dyspnea-recovery time over a 4-week period.

干预措施: Non-Invasive Ventilation (Device)

结局指标

主要结局

Change of daily physical activity measured by actimetry

时间窗: Continuously over a 8-week period (2 weeks before the use of the device, over the 4-week period usinf the device and 2 weeks after the use of the device

Change of number of steps by day and daily energy expenditure over the 8 week period

次要结局

  • Change of Transition Dyspnea Index (TDI)(baseline and post use of the Vitabreath device at 4th weeks)
  • Change of Chronic Obstructive Pulmonary Disease Assessment Test (CAT)score(Continuously over a 8-week period (2 weeks before the use of the device, over the 4-week period usinf the device and 2 weeks after the use of the device)
  • Subjective appréciation of the device(post use of the Vitabreath device at 4th weeks)
  • Change of Modified Medical Research Council Questionnaire (mMRC) score(baseline and post use of the Vitabreath device at 4th weeks)
  • Change of Baseline Dyspnea Index (BDI) score(baseline and post use of the Vitabreath device at 4th weeks)
  • Change of Visual Simplified Respiratory Questionnaire (VSRQ) score(baseline and post use of the Vitabreath device at 4th weeks)

研究者

发起方
Icadom
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验

Wearable Noninvasive Positive Pressure Ventilation... | 临床试验